| Primary |
| Type 1 Diabetes Mellitus |
37.9% |
| Type 2 Diabetes Mellitus |
19.0% |
| Product Used For Unknown Indication |
17.2% |
| Diabetes Mellitus |
12.1% |
| Hyperglycaemia |
10.3% |
| Diabetes |
1.7% |
| Hyperkalaemia |
1.7% |
|
| Blood Glucose Decreased |
11.8% |
| Blood Glucose Increased |
11.8% |
| Hypoglycaemia |
11.8% |
| Lethargy |
11.8% |
| Somnolence |
5.9% |
| Tremor |
5.9% |
| Depressed Level Of Consciousness |
2.9% |
| Diabetic Ketoacidosis |
2.9% |
| Dizziness |
2.9% |
| Erectile Dysfunction |
2.9% |
| Feeling Cold |
2.9% |
| Hyperhidrosis |
2.9% |
| Hypoglycaemic Seizure |
2.9% |
| Incoherent |
2.9% |
| Loss Of Consciousness |
2.9% |
| Medication Error |
2.9% |
| Mental Status Changes |
2.9% |
| Nausea |
2.9% |
| Paraesthesia Oral |
2.9% |
| Tachycardia |
2.9% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
38.8% |
| Type 1 Diabetes Mellitus |
11.5% |
| Drug Use For Unknown Indication |
10.5% |
| Diabetes Mellitus |
9.7% |
| Product Used For Unknown Indication |
3.8% |
| Hypertension |
3.3% |
| General Anaesthesia |
2.5% |
| Anaesthesia |
2.2% |
| Antiretroviral Therapy |
2.2% |
| Hyperemesis Gravidarum |
1.9% |
| Schizophrenia |
1.9% |
| Constipation |
1.7% |
| Hyperglycaemia |
1.6% |
| Hypokalaemia |
1.6% |
| Hypotonia |
1.6% |
| Sedation |
1.3% |
| Depression |
1.1% |
| Rhinitis Allergic |
0.9% |
| Sinusitis |
0.9% |
| Type I Diabetes Mellitus |
0.9% |
|
| Hypotension |
17.1% |
| Renal Failure Acute |
12.6% |
| Pulmonary Oedema |
9.0% |
| Vomiting |
8.1% |
| Loss Of Consciousness |
7.2% |
| Nausea |
7.2% |
| Pancreatitis |
4.5% |
| Herpes Zoster Infection Neurological |
3.6% |
| Hypoglycaemia |
3.6% |
| Insulin C-peptide Decreased |
3.6% |
| Hyperglycaemia |
2.7% |
| Mental Status Changes |
2.7% |
| Syncope |
2.7% |
| Systemic Inflammatory Response Syndrome |
2.7% |
| Vaginal Discharge |
2.7% |
| Weight Increased |
2.7% |
| Blood Glucose Increased |
1.8% |
| Cutaneous Amyloidosis |
1.8% |
| Dehydration |
1.8% |
| Hyperhidrosis |
1.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
28.0% |
| Product Used For Unknown Indication |
28.0% |
| Diabetes Mellitus |
12.1% |
| Type 2 Diabetes Mellitus |
5.6% |
| Hypertension |
4.6% |
| Pain |
2.8% |
| Rheumatoid Arthritis |
2.4% |
| Prophylaxis |
1.9% |
| Type 1 Diabetes Mellitus |
1.5% |
| Depression |
1.5% |
| T-cell Type Acute Leukaemia |
1.4% |
| Medical Diet |
1.4% |
| Coronary Artery Disease |
1.4% |
| Adverse Event |
1.2% |
| Constipation |
1.1% |
| Hypercholesterolaemia |
1.1% |
| Thrombosis Prophylaxis |
1.1% |
| Asthma |
1.0% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Aplastic Anaemia |
0.9% |
|
| Vomiting |
12.5% |
| Pyrexia |
11.1% |
| Hypoglycaemia |
7.2% |
| Respiratory Failure |
6.8% |
| Nausea |
5.4% |
| Renal Failure |
5.4% |
| Atrial Fibrillation |
5.0% |
| Renal Failure Acute |
5.0% |
| Renal Impairment |
4.3% |
| Loss Of Consciousness |
3.9% |
| Weight Decreased |
3.9% |
| Rhabdomyolysis |
3.6% |
| Death |
3.2% |
| Eosinophilic Myocarditis |
3.2% |
| Hepatic Function Abnormal |
3.2% |
| Pneumonia |
3.2% |
| Somnolence |
3.2% |
| Staphylococcal Infection |
3.2% |
| Syncope |
3.2% |
| Wheezing |
3.2% |
|
| Interacting |
| Drug Use For Unknown Indication |
73.3% |
| Diabetes Mellitus Insulin-dependent |
8.3% |
| Diabetes Mellitus |
3.3% |
| Hypertension |
3.3% |
| Neuralgia |
3.3% |
| Rheumatoid Arthritis |
3.3% |
| Back Pain |
1.7% |
| Pain |
1.7% |
| Restlessness |
1.7% |
|
| Hypoglycaemia |
71.4% |
| Drug Interaction |
14.3% |
| Urinary Incontinence |
14.3% |
|
